Sarepta Therapeutics shares were higher after J.P. Morgan reduced its December 2025 price target to $84 from $169 and maintained its overweight rating. The stock was up 4% to $39.55 Tuesday and is ...

Investors at the Morningstar Investment Conference share which companies they are backing amid the wild market swings.

Learn the differences between S&P 500 and total market index funds across key factors, including volatility, growth, past performance, and market exposure.

The president's press secretary said tax bill 'does not add to the deficit' President Donald Trump's press secretary, Karoline Leavitt, made a sweeping claim Monday, arguing that the president's tax ...